A potential COVID-19 vaccine being developed by Chinese researchers showed promise in trials in monkeys, triggering antibodies and raising no safety issues, researchers said, and a human trial with more than 1,000 participants is under way.
The vaccine candidate, called BBIBP-CorV, induced high-level neutralizing antibodies that can block the virus from infecting cells in monkeys, rats, guinea pigs and rabbits, researchers said in a paper published in online by the medical journal Cell on Saturday.
For more on coronavirus, visit our dedicated section.
“These results support the further evaluation of BBIBP-CorV in a clinical trial,” researchers said in the paper.
BBIBP-CorV, developed by Beijing Institute of Biological Products affiliated to state-owned China National Pharmaceutical Group (Sinopharm), is among five candidates China is testing in humans.
More than 100 potential COVID-19 vaccines are in various stages of development around the world. Among front runners currently in human trials are being developed by AstraZeneca, Pfizer, BioNtech, Johnson & Johnson, Merck, Moderna, Sanofi and China’s CanSino Biologics.
Read more: Remdesivir, favipiravir, famotidine: Discover coronavirus vaccines, drugs in progress
As well as appearing safe and able to generate an immune response in animals, BBIBP-CorV did not appear to trigger antibodies that could boost the infection – a phenomenon known as antibody-dependent enhancement (ADE) – the researchers said, although this does not necessarily guarantee ADE won’t occur in human tests.
Apart from BBIBP-CorV, Sinopharm, which has invested 1 billion yuan ($141.40 million) in vaccine projects, is testing in humans another vaccine candidate developed by its Wuhan-based unit. The two shots have been given to more than 2,000 people in clinical trials.
Read more:
Coronavirus: Vaccines, medicine must be fairly shared to beat outbreak, WHO head says
Coronavirus: China vows to make COVID-19 vaccine a ‘global public good’ once ready
Coronavirus vaccine: Monkeys infected with COVID-19 develop immunity in studies
Also Read
-
Bill Gates responds to ‘stupid,’ ‘bizarre’ coronavirus microchip conspiracy theories
Responding to a conspiracy theory that Bill Gates plans to use the coronavirus vaccine to implant microchips in people and create a global ... Coronavirus -
Coronavirus ‘removed’ from Tanzania due to the ‘powers of God:’ President
Tanzania is coronavirus free due to the power of prayer, according to the country’s president, six weeks after officials stopped updating statistics ... Coronavirus -
Coronavirus: Kuwait records 683 new cases, 1,126 recoveries in 24 hours
Kuwait recorded 683 new coronavirus cases in the past 24 hours, which raises the total number of confirmed infections in the country to 33,823, the ... Coronavirus -
Coronavirus: Polish scientists design remote-controlled ventilator
A team of Polish scientists has designed a remote-controlled ventilator they hope will allow doctors to help critically ill patients breathe, but from ... Coronavirus
